Transanal transabdominal TME: how far can we push it?

Minerva Chir. 2018 Dec;73(6):579-591. doi: 10.23736/S0026-4733.18.07827-6. Epub 2018 Jul 18.

Abstract

Over many decades, advances in surgical technology, such as the use of the electrocautery Bovie, development of minimally invasive and advanced endoscopic platforms and the ability to create and maintain pneumorectum have propelled surgical techniques forward to today, with development of the transanal total mesorectal excision TME (taTME) for en bloc resection of rectal cancers. The transanal platform offers, for now, a viable alternative to perform safe and oncologically sound TME, especially favorable in cases of low rectal lesions in a narrow pelvis post neoadjuvant treatment. The aspiration of the colorectal community remains to continue to push the operative boundaries whilst maintaining safe oncological principals with the best possible functional outcomes for patients. In this article we review this evolving technique and focus on future directions.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Endoscopes
  • Forecasting
  • Humans
  • Interdisciplinary Communication
  • Intraoperative Complications / etiology
  • Intraoperative Complications / prevention & control
  • Lymph Node Excision / methods
  • Margins of Excision
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Patient Care Team
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Practice Guidelines as Topic
  • Preoperative Care
  • Rectal Neoplasms / diagnostic imaging
  • Rectal Neoplasms / radiotherapy
  • Rectal Neoplasms / surgery*
  • Registries
  • Robotic Surgical Procedures
  • Transanal Endoscopic Surgery* / adverse effects
  • Transanal Endoscopic Surgery* / instrumentation
  • Transanal Endoscopic Surgery* / methods
  • Transanal Endoscopic Surgery* / trends
  • Treatment Outcome